TY - JOUR
T1 - Transcriptional Regulation in Melanoma
AU - Mitra, Devarati
AU - Fisher, David E.
N1 - Funding Information:
This work was supported by grants from NIH and the Melanoma Research Alliance. DEF is a Distinguished Clinical Scholar of the Doris Duke Medical Foundation.
PY - 2009/6
Y1 - 2009/6
N2 - Transcriptional regulation in melanoma is a complex process that tends to hijack the normal melanocyte signaling pathways involved in melanocyte development, pigmentation, and survival. At the center of these often overlapping networks of transcriptional activation and repression is microphthalmia-associated transcription factor (MITF), a melanocyte lineage marker that increases pigment production and exhibits diverse effects on cell survival, proliferation, and cell cycle arrest. The particular conditions that allow MITF to produce these potentially contradictory roles have not yet been fully elucidated, but analysis of the pathways involved provides opportunities to learn about new therapeutic strategies.
AB - Transcriptional regulation in melanoma is a complex process that tends to hijack the normal melanocyte signaling pathways involved in melanocyte development, pigmentation, and survival. At the center of these often overlapping networks of transcriptional activation and repression is microphthalmia-associated transcription factor (MITF), a melanocyte lineage marker that increases pigment production and exhibits diverse effects on cell survival, proliferation, and cell cycle arrest. The particular conditions that allow MITF to produce these potentially contradictory roles have not yet been fully elucidated, but analysis of the pathways involved provides opportunities to learn about new therapeutic strategies.
KW - Melanocyte survival
KW - Melanoma
KW - Microphthalmia-associated transcription factor
KW - Therapeutic opportunities in melanoma
KW - Transcriptional regulation
UR - http://www.scopus.com/inward/record.url?scp=65749085328&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=65749085328&partnerID=8YFLogxK
U2 - 10.1016/j.hoc.2009.03.003
DO - 10.1016/j.hoc.2009.03.003
M3 - Review article
C2 - 19464596
AN - SCOPUS:65749085328
SN - 0889-8588
VL - 23
SP - 447
EP - 465
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
IS - 3
ER -